Pfizer (PFE) Named Global Top Pick at Jefferies

Jefferies analyst Jeffrey Holford made Pfizer (NYSE: PFE) its Global 'Top Pick' in the sector while reiterating a Buy rating and price target of $47.

Holford expects fundamentals and self help through M&A and restructuring to drive outperformance.

AbbVie (NYSE: ABBV), which is in 2nd place, remains significantly undervalued in their view. The firm maintained a Buy rating and trimmed its price target to $85.

For an analyst ratings summary and ratings history on Pfizer click here. For more ratings news on Pfizer click here.

Shares of Pfizer closed at $31.96 yesterday.

You May Also Be Interested In

• Qualcomm (QCOM) PT Raised to $265 at Rosenblatt
• Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
• Micron Technology (MU) PT Raised to $1,650 at Needham